Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review.

Background: Solifenacin is an anticholinergic that is used to treat overactive bladder syndrome (OAB) in children. It is important to ascertain the safety and tolerability of solifenacin in the paediatric population as solifenacin offers an alternative, is more bladder specific, and should have less anticholinergic side effects than other therapies.

Objective: The aim of this study is to systematically evaluate the safety and tolerability of solifenacin in children and adolescents with OAB.

Kawasaki Disease in the Australian Population: An Australian Tertiary Hospital Experience.

Aim: To describe the contemporary experience of Kawasaki Disease (KD) in a tertiary paediatric hospital.

Methods: This was a retrospective analysis of admissions with suspected/confirmed KD to John Hunter Children's Hospital from 1 January 2015 to 31 December 2016, with follow-up. Patients were stratified into classical, incomplete, unlikely and uncertain KD cohorts based on the 2004 American Heart Association (AHA) guidelines.